Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07488793 · ClinicalTrials.gov registry record · NA

Remote Ischemic Conditioning for PwSCI

A NA study of Spinal Cord Injuries, sponsored by Washington University School of Medicine.

Recruiting
Registry status
NA
Development phase
24
Enrollment target
1
Study location

NCT07488793: Recruiting NA study of Spinal Cord Injuries, sponsored by Washington University School of Medicine.

NCT07488793 is a NA study of Spinal Cord Injuries that is actively recruiting participants, run by Washington University School of Medicine. The registered enrollment target is 24 participants, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (61% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07488793, a NA study of Spinal Cord Injuries, is actively recruiting participants, sponsored by Washington University School of Medicine.

RECRUITING
Registry status
NA
Development phase
24 participants
Enrollment target
1
Study location

Study Summary

The long-term goal of this project is to improve the overall cardiometabolic health of persons with spinal cord injury (SCI). This pilot study will test the feasibility and acceptability of remote ischemic conditioning implemented in a home setting by persons with SCI and collect cardiometabolic health outcomes to inform appropriate outcomes for a future larger trial. Researchers will compare, RIC high dose using standard blood pressure cuff to RIC high dose using automated blood flow restriction cuff to RIC low dose using standard blood pressure cuff, to determine cardiometabolic health improvements amongst groups. Participants will: Complete an initial 2-day assessment, participate in a 6-week intervention using remote ischemic conditioning (RIC) within their home, complete a 2-day post assessment.

Primary Outcome

Participants will undergo a Brachial Artery Reactivity Test (BART) via upper arm doppler ultrasound. The test will measure flow-mediated dilation and endothelium independent dilation of the brachial artery using a high-resolution transducer on the Vivid E95, E9, Vivid IQ (portable) or Vivid I (portable) systems. Brachial artery flow-mediated vasodilation correlates with measures of coronary artery endothelial function and can predict future adverse coronary events. Results will be reported as br

Conditions Studied

Interventions

  • BEHAVIORAL RIC high-dose standard blood pressure cuff
  • BEHAVIORAL RIC high-dose automated blood flow restriction cuff
  • BEHAVIORAL RIC low-dose standard blood pressure cuff

Study Locations (1)

Missouri

  • Washington University School of Medicine - St Louis

Trial Details

FieldValue
Enrollment Target 24 participants
Start Date 2026-02-23
Est. Completion 2027-07-30
Phase NA

What NCT07488793 shows while recruiting

NCT07488793 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 24 participants, a relatively small participant target, below the 61-participant average among 202 other Spinal Cord Injuries trials with a reported enrollment target (61% lower).

The record links to 1 condition, with Spinal Cord Injuries appearing as the primary indexed condition, and to 3 interventions - of which RIC high-dose standard blood pressure cuff is the first listed.

NCT07488793 reports a single indexed study location in Missouri.

Frequently Asked Questions

What is clinical trial NCT07488793 about?

NCT07488793 is a clinical study titled "Remote Ischemic Conditioning for PwSCI". The long-term goal of this project is to improve the overall cardiometabolic health of persons with spinal cord injury (SCI). This pilot study will test the feasibility and acceptability of remote ischemic conditioning implemented in a home setting by persons with SCI and collect cardiometabolic hea...

What is the current status of trial NCT07488793?

This trial is currently recruiting. It is a NA study. The enrollment target is 24 participants. The study started on 2026-02-23. Estimated completion is 2027-07-30.

What conditions does trial NCT07488793 study?

This clinical trial studies the following conditions: Spinal Cord Injuries.

What interventions are being tested in trial NCT07488793?

The interventions under investigation include: RIC high-dose standard blood pressure cuff (BEHAVIORAL), RIC high-dose automated blood flow restriction cuff (BEHAVIORAL), RIC low-dose standard blood pressure cuff (BEHAVIORAL).

Who is sponsoring clinical trial NCT07488793?

This trial is sponsored by Washington University School of Medicine, which has 1,502 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07488793 being conducted?

This trial has 1 study location across Missouri. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Spinal Cord Injuries

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT07488793's enrollment target sits among peer trials

24 114th of 202 higher than 82 of 202 other Spinal Cord Injuries trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Spinal Cord Injuries trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02331979 · 24 participants · NA

    Improving Bladder Function in SCI by Neuromodulation

  • NCT03096197 · 24 participants · NA

    Exoskeleton and Spinal Cord Stimulation for SCI

  • NCT03223922 · 24 participants · NA

    Neurocognitive Functioning With Genu-Sparing Whole Brain Radiation Therapy for Brain Metastases

  • NCT03326921 · 24 participants · Phase 1

    HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT06358040 · started 2026-10 · NA

    Opioid Dispenser for Microdiscectomy/Laminectomy

Source: ClinicalTrials.gov NCT07488793, the US trial registry maintained by the National Library of Medicine. NCT07488793 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.